Study probes link between transfusions and gut trouble in preterm infants
NCT ID NCT02741648
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 324 extremely low birth weight preterm infants (≤1250 grams) to see how anemia and red blood cell transfusions affect oxygen levels in their digestive tract. Researchers used a non-invasive device to measure tissue oxygen and collected blood, urine, and stool samples. The goal was to find clues that might explain why some babies develop necrotizing enterocolitis, a serious gut condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors better understand why some preterm infants develop a serious gut condition called necrotizing enterocolitis after a transfusion.
- What could go wrong
- This is an observational study, not a treatment trial. It aims to gather information, not test a new therapy, so it will not directly change care yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
324 people
The number who actually took part.
- Started
-
Jul 2016
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Extremely low birth weight newborn infants born at Emory University Hospital Midtown, Grady Health System, and Northside Hospital Neonatology. Infants will be followed at Children's Healthcare of Atlanta.
- Ages
-
1 day to 5 days
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Birth weight ≤1250 grams * Postnatal age within 7 days of birth Exclusion Criteria: * Infant not expected to live beyond 7 days of life based on assessment of treating neonatologist * Severe congenital abnormality expected to affect life expectancy * RBC or platelet transfusion at an outside institution occurring prior to screening * Maternal refusal to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anemia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
-
Grady Memorial Hospital
Atlanta, Georgia, 30303, United States
-
Northside Hospital - Neonatology
Atlanta, Georgia, 30342, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fecal calprotectin level in breastfed versus Formula-Fed preterm infants as an early indicator of developing necrotizing enterocolitis: a One-Year study
- Can scheduled malaria drugs shield infants from severe illness?
- Can a simple preventive drug cut malaria and anemia in infants?
- Can catching anemia months before joint surgery speed recovery?
- Can a simple blood test predict surgery risks?
- Can a new injection match the standard for dialysis anemia?